122 related articles for article (PubMed ID: 18795672)
1. Anti-proliferative effect of interferon-gamma is enhanced by iron chelation in colon cancer cell lines in vitro.
Mori S; Sawada T; Okada T; Kubota K
Hepatogastroenterology; 2008; 55(85):1274-9. PubMed ID: 18795672
[TBL] [Abstract][Full Text] [Related]
2. Deferoxamine enhances anti-proliferative effect of interferon-gamma against hepatocellular carcinoma cells.
Okada T; Sawada T; Kubota K
Cancer Lett; 2007 Apr; 248(1):24-31. PubMed ID: 16837131
[TBL] [Abstract][Full Text] [Related]
3. Iron chelator-induced growth arrest and cytochrome c-dependent apoptosis in immortalized and malignant oral keratinocytes.
Lee SK; Lee JJ; Lee HJ; Lee J; Jeon BH; Jun CD; Lee SK; Kim EC
J Oral Pathol Med; 2006 Apr; 35(4):218-26. PubMed ID: 16519769
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death.
Bernabei P; Coccia EM; Rigamonti L; Bosticardo M; Forni G; Pestka S; Krause CD; Battistini A; Novelli F
J Leukoc Biol; 2001 Dec; 70(6):950-60. PubMed ID: 11739558
[TBL] [Abstract][Full Text] [Related]
5. Cytokine induced apoptosis in human retinoblastoma cells.
Cullinan AE; Brandt CR
Mol Vis; 2004 Apr; 10():315-22. PubMed ID: 15133451
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the activation of Stat1 by the interferon-gamma receptor complex.
Krause CD; He W; Kotenko S; Pestka S
Cell Res; 2006 Jan; 16(1):113-23. PubMed ID: 16467883
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD40 and growth-inhibitory activity of CD40 ligand in colon cancer ex vivo.
Wu Y; Wang L; He X; Xu H; Zhou L; Zhao F; Zhang Y
Cell Immunol; 2008; 253(1-2):102-9. PubMed ID: 18603231
[TBL] [Abstract][Full Text] [Related]
8. Iron chelators deferoxamine and diethylenetriamine pentaacetic acid induce apoptosis in ovarian carcinoma.
Brard L; Granai CO; Swamy N
Gynecol Oncol; 2006 Jan; 100(1):116-27. PubMed ID: 16203029
[TBL] [Abstract][Full Text] [Related]
9. Differential gamma-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth.
Pfizenmaier K; Bartsch H; Scheurich P; Seliger B; Ucer U; Vehmeyer K; Nagel GA
Cancer Res; 1985 Aug; 45(8):3503-9. PubMed ID: 3160456
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated murine interferon-gamma receptor transfer enhances the efficacy of IFN-gamma in vivo.
Nishida Y; Maeda Y; Hara A; Arima T; Kimura E; Yamashita S; Uyama E; Mita S; Uchino M
Biochem Biophys Res Commun; 2002 Jan; 290(3):1042-7. PubMed ID: 11798180
[TBL] [Abstract][Full Text] [Related]
11. Effect of amino acid substitutions in the human IFN-γR2 on IFN-γ responsiveness.
de Paus RA; Kilic SS; van Dissel JT; van de Vosse E
Genes Immun; 2011 Mar; 12(2):136-44. PubMed ID: 21248774
[TBL] [Abstract][Full Text] [Related]
12. Iron regulates T-lymphocyte sensitivity to the IFN-gamma/STAT1 signaling pathway in vitro and in vivo.
Regis G; Bosticardo M; Conti L; De Angelis S; Boselli D; Tomaino B; Bernabei P; Giovarelli M; Novelli F
Blood; 2005 Apr; 105(8):3214-21. PubMed ID: 15626737
[TBL] [Abstract][Full Text] [Related]
13. Partial interferon-gamma receptor deficiency and non-tuberculous mycobacterial lung disease.
Hwang JH; Koh WJ; Kim EJ; Kang EH; Suh GY; Chung MP; Kim H; Kwon OJ
Tuberculosis (Edinb); 2006 Sep; 86(5):382-5. PubMed ID: 16682253
[TBL] [Abstract][Full Text] [Related]
14. The antineoplastic agent bryostatin-1 differentially regulates IFN-gamma receptor subunits in monocytic cells: transcriptional and posttranscriptional control of IFN-gamma R2.
Garcia CS; Curiel RE; Mwatibo JM; Pestka S; Li H; Espinoza-Delgado I
J Immunol; 2006 Aug; 177(4):2707-16. PubMed ID: 16888033
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: effect on the R2 subunit of ribonucleotide reductase.
Green DA; Antholine WE; Wong SJ; Richardson DR; Chitambar CR
Clin Cancer Res; 2001 Nov; 7(11):3574-9. PubMed ID: 11705879
[TBL] [Abstract][Full Text] [Related]
16. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
17. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
[TBL] [Abstract][Full Text] [Related]
18. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a dipeptide motif regulating IFN-gamma receptor 2 plasma membrane accumulation and IFN-gamma responsiveness.
Rosenzweig SD; Schwartz OM; Brown MR; Leto TL; Holland SM
J Immunol; 2004 Sep; 173(6):3991-9. PubMed ID: 15356148
[TBL] [Abstract][Full Text] [Related]
20. IFN-γ and its receptors in a reptile reveal the evolutionary conservation of type II IFNs in vertebrates.
Chen SN; Huang B; Zhang XW; Li Y; Zhao LJ; Li N; Gao Q; Nie P
Dev Comp Immunol; 2013 Dec; 41(4):587-96. PubMed ID: 23850722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
